Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine?
- PMID: 15173036
- DOI: 10.1161/01.CIR.0000130730.63776.69
Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine?
Comment on
-
Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery.Circulation. 2004 May 11;109(18):2172-4. doi: 10.1161/01.CIR.0000128862.34201.74. Epub 2004 Apr 26. Circulation. 2004. PMID: 15117834 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
